Tezepelumab significantly reduced asthma exacerbations: Phase 3 NAVIGATOR trial
by American Thoracic SocietyObstruction of the lumen of a bronchiole by mucoid exudate, goblet cell metaplasia, and epithelial basement membrane thickening in a person with asthma. Credit: Yale R
Updated on: May 08,2024
5

Tezepelumab significantly reduced asthma exacerbations: Phase 3 NAVIGATOR trial
by American Thoracic SocietyObstruction of the lumen of a bronchiole by mucoid exudate, goblet cell metaplasia, and epithelial basement membrane thickening in a person with asthma. Credit: Yale R
Updated on:May 08,2024
5
